Navigation Links
Shark Cartilage Not Beneficial in Advanced Lung Cancer
Date:5/26/2010

Study found no difference in survival when compared to chemoradiotherapy alone

WEDNESDAY, May 26 (HealthDay News) -- A drug derived from shark cartilage failed to improve survival in patients with advanced lung cancer, researchers report.

The disappointing results, which came in the final stage of testing, showed that the drug didn't help extend the life spans of patients with inoperable stage III non-small cell lung cancer.

Scientists have been testing drugs derived from shark cartilage because it appears to prevent blood vessels from growing around tumors. The hope is that the drugs will prevent cancer cells from being fed by blood, which allows them to grow.

Researchers led by Dr. Charles Lu, of the University of Texas M.D. Anderson Cancer Center, tested the specific drug in question, known as AE-941, on patients in the United States and Canada.

In the study, published online May 26 in the Journal of the National Cancer Institute, a total of 379 patients with inoperable non-small cell lung cancer were treated with chemoradiotherapy and either AE-941 or an inactive placebo.

There was no significant difference in outcome between the two groups in terms of overall survival, or in length of time before the disease progressed, the researchers found.

The study authors noted that the study's impetus was "the widespread use of poorly regulated complementary and alternative medicine products, such as shark cartilage-derived agents, among patients with advanced cancer, a population likely to be vulnerable to unsubstantiated marketing claims."

More information

For more on lung cancer, try the U.S. National Library of Medicine.



-- Randy Dotinga



SOURCE: Oxford Journals, news release, May 26, 2010


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved

Related medicine news :

1. Shark Attack Study Announced: Politics of Bite Incidents Under Review
2. Nanofiber Gel May Spur Growth of New Knee Cartilage
3. Cartilage repair can improve life, ease burden on health services
4. NIH study confirms location of stem cells near cartilage-rich regions in bones
5. Major New Study Finds Soyfoods Safe and Beneficial for Women With Breast Cancer
6. Soy Beneficial for Breast Cancer Survivors: Study
7. Medication appears well-tolerated, beneficial in Huntingtons disease patients
8. Chocolate Industry Leaders Sign Agreement, Align on Path Towards Increasing Consumer Availability & Consistency of Beneficial Cocoa Flavanols
9. Screens, Vaccine for HPV Less Beneficial in Older Women
10. Beneficial Microorganisms Rescue Chilean Earthquake Victims
11. Probiotics Beneficial for Tiniest Preemies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/8/2016)... ... 2016 , ... Brenntag Specialties, Inc.(BSI) , is pleased ... Beverage and Dietary Supplement market segments across the western United ... east of the Rocky Mountains since 2012. Consistent performance in business development ...
(Date:2/8/2016)... ... February 08, 2016 , ... A man who has struggled to quit smoking, a man ... , was determined to find solutions to his problems – and he did. Now Nabat, ... is ready to introduce his breakthrough inventions to the world and better people's lives. His ...
(Date:2/8/2016)... Head Island, SC (PRWEB) , ... February 08, 2016 , ... ... and surrounding areas with a vital new community enrichment program, has teamed up with ... local women and children suffering from intimate abuse. To support all those victimized by ...
(Date:2/8/2016)... ... February 08, 2016 , ... ... executive networking and relationship-marketing firm, announced today that nominations will be accepted ... Executive® (ISE®) West Awards. , Awards include the Information Security Executive® ...
(Date:2/8/2016)... ... ... the Rocky Mountain region’s longest running and impressive garden and home show where you ... the most incredible gardens and home improvement experts that attend this amazing show. ... 700 14th St. Denver CO, is an exciting event that Performance Mobility has enjoyed ...
Breaking Medicine News(10 mins):
(Date:2/8/2016)... -- CTI BioPharma Corp. (CTI BioPharma) (NASDAQ and MTA:CTIC) today ... U.S. Food and Drug Administration (FDA) on February 4, ... hold on the clinical studies being conducted under the ... clinical hold impacts part of the clinical work currently ... planned clinical trials. --> ...
(Date:2/5/2016)... IRVINE, Calif. , Feb. 5, 2016 /PRNewswire/ ... leading global aesthetic device company, announced today that ... Syneron Candela North America, is scheduled to participate ... Global Healthcare Conference on February 11, 2016 in ... conference will allow institutional investors to meet with ...
(Date:2/5/2016)... http://www.researchandmarkets.com/research/jsc97m/global ) ... "Global Musculoskeletal Partnering 2010-2016: Deal trends, players ... offering. --> http://www.researchandmarkets.com/research/jsc97m/global ) ... "Global Musculoskeletal Partnering 2010-2016: Deal trends, players ... offering. --> Research and ...
Breaking Medicine Technology: